Figure 4.

Cdh1 KO promotes KP-driven gastric tumorigenesis. (A) Bright-field images of KP and EKP cells in low and high magnification. Scale bars: 100 μm (upper panels); 50 μm (lower panels). (B) Crystal violet staining of KP and EKP GOs-derived cells. (C) Bright-field images of KP and EKP allograft tumors; tumor incidence of allograft tumors. (D and E) Plot for tumor mass (D) and tumor size (E) assessment of KP and EKP allografts. (F) H&E staining of KP and EKP allograft tumors (n ≥ 3). Scale bars (from left to right): 50, 200, 50 μm; Md: middle; Ct: cortex. (G and H) Immunostaining of KP and EKP allograft tumors (n ≥ 3) for MKI67 (G) and E-cadherin (H). Scale bars: 50 μm. (I) Statistics analysis of MKi67 staining in Fig. 4 G. P values were calculated using Student’s t test; error bars: SD. (J–O) CD3 (J), CD4 (K), CD8 (L), PDCD1 (M), TIM3 (N) staining and CD11B/LY6G co-staining (O) of KP and EKP allograft tumors (n ≥ 3). Left panels (low magnification [low mag]; right panels (high magnification [high mag]). Scale bars: 50 μm (low mag) and 20 μm (high mag). (P–U) Statistics analysis of CD3 (P), CD4 (Q), CD8 (R), PDCD1 (S), TIM3 (T) staining and CD11B/LY6G co-staining (U). The positive cell percentage indicates the area of cells expressing a specific marker divided by the total field–occupied cells stained by DAPI in the same area, which allows for normalization. Md: middle; Ct: cortex. P values were calculated using the one-way ANOVA; error bars: SD. ns: P > 0.05; *: P ≤ 0.05; **: P ≤ 0.01; ***: P ≤ 0.001. All data are derived from two or more independent experiments with the indicated number of mice.

or Create an Account

Close Modal
Close Modal